-
1
-
-
78049355534
-
Antiviral drug resistance of human cytomegalovirus
-
Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010;23(4):689-712.
-
(2010)
Clin Microbiol Rev
, vol.23
, Issue.4
, pp. 689-712
-
-
Lurain, N.S.1
Chou, S.2
-
2
-
-
2442457528
-
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients
-
Boivin G, Goyette N, Gilbert C, et al. Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis. 2004;189(9):1615-1618.
-
(2004)
J Infect Dis
, vol.189
, Issue.9
, pp. 1615-1618
-
-
Boivin, G.1
Goyette, N.2
Gilbert, C.3
-
3
-
-
69849110029
-
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
-
Boivin G, Goyette N, Rollag H, et al. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther. 2009;14(5):697-704.
-
(2009)
Antivir Ther
, vol.14
, Issue.5
, pp. 697-704
-
-
Boivin, G.1
Goyette, N.2
Rollag, H.3
-
4
-
-
0036137356
-
High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy
-
Limaye AP, Raghu G, Koelle DM, Ferrenberg J, Huang ML, Boeckh M. High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis. 2002;185(1):20-27.
-
(2002)
J Infect Dis
, vol.185
, Issue.1
, pp. 20-27
-
-
Limaye, A.P.1
Raghu, G.2
Koelle, D.M.3
Ferrenberg, J.4
Huang, M.L.5
Boeckh, M.6
-
5
-
-
0036906529
-
Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients
-
Bhorade SM, Lurain NS, Jordan A, et al. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant. 2002;21(12):1274-1282.
-
(2002)
J Heart Lung Transplant
, vol.21
, Issue.12
, pp. 1274-1282
-
-
Bhorade, S.M.1
Lurain, N.S.2
Jordan, A.3
-
6
-
-
0036789258
-
Ganciclovir-resistant cytomegalovirus in organ transplant recipients
-
Limaye AP. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin Infect Dis. 2002;35(7):866-872.
-
(2002)
Clin Infect Dis
, vol.35
, Issue.7
, pp. 866-872
-
-
Limaye, A.P.1
-
7
-
-
84874828991
-
Cytomegalovirus in solid organ transplantation
-
Razonable RR, Humar A, Practice ASTIDCo. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):93-106.
-
(2013)
Am J Transplant
, vol.13
, pp. 93-106
-
-
Razonable, R.R.1
Humar, A.2
-
8
-
-
85046370425
-
The Third International Consensus Guidelines on the management of Cytomegalovirus in solid organ transplantation
-
Kotton CN, Kumar D, Caliendo AM, et al. The Third International Consensus Guidelines on the management of Cytomegalovirus in solid organ transplantation. Transplantation. 2018;102:900-931.
-
(2018)
Transplantation
, vol.102
, pp. 900-931
-
-
Kotton, C.N.1
Kumar, D.2
Caliendo, A.M.3
-
9
-
-
84982840819
-
Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory Cytomegalovirus infection
-
Avery RK, Arav-Boger R, Marr KA, et al. Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory Cytomegalovirus infection. Transplantation. 2016;100(10):e74-e80.
-
(2016)
Transplantation
, vol.100
, Issue.10
, pp. e74-e80
-
-
Avery, R.K.1
Arav-Boger, R.2
Marr, K.A.3
-
10
-
-
84939810237
-
Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human Cytomegalovirus
-
Melendez DP, Razonable RR. Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human Cytomegalovirus. Infect Drug Resist. 2015;8:269-277.
-
(2015)
Infect Drug Resist
, vol.8
, pp. 269-277
-
-
Melendez, D.P.1
Razonable, R.R.2
-
11
-
-
84899819902
-
Letermovir for Cytomegalovirus prophylaxis in hematopoietic-cell transplantation
-
Chemaly RF, Ullmann AJ, Stoelben S, et al. Letermovir for Cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014;370(19):1781-1789.
-
(2014)
N Engl J Med
, vol.370
, Issue.19
, pp. 1781-1789
-
-
Chemaly, R.F.1
Ullmann, A.J.2
Stoelben, S.3
-
12
-
-
85039768345
-
Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation
-
Marty FM, Ljungman P, Chemaly RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377(25):2433-2444.
-
(2017)
N Engl J Med
, vol.377
, Issue.25
, pp. 2433-2444
-
-
Marty, F.M.1
Ljungman, P.2
Chemaly, R.F.3
-
13
-
-
79955544310
-
First report of successful treatment of multidrug-resistant Cytomegalovirus disease with the novel anti-CMV compound AIC246
-
Kaul DR, Stoelben S, Cober E, et al. First report of successful treatment of multidrug-resistant Cytomegalovirus disease with the novel anti-CMV compound AIC246. Am J Transplant. 2011;11(5):1079-1084.
-
(2011)
Am J Transplant
, vol.11
, Issue.5
, pp. 1079-1084
-
-
Kaul, D.R.1
Stoelben, S.2
Cober, E.3
-
14
-
-
84896497988
-
Preemptive treatment of cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study
-
Stoelben S, Arns W, Renders L, et al. Preemptive treatment of cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study. Transpl Int. 2014;27(1):77-86.
-
(2014)
Transpl Int
, vol.27
, Issue.1
, pp. 77-86
-
-
Stoelben, S.1
Arns, W.2
Renders, L.3
-
15
-
-
77149133052
-
In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246
-
Lischka P, Hewlett G, Wunberg T, et al. In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob Agents Chemother. 2010;54(3):1290-1297.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.3
, pp. 1290-1297
-
-
Lischka, P.1
Hewlett, G.2
Wunberg, T.3
-
16
-
-
85030637189
-
Pharmacokinetics and safety of letermovir coadministered with cyclosporine A or tacrolimus in healthy subjects
-
Kropeit D, von Richter O, Stobernack HP, Rubsamen-Schaeff H, Zimmermann H. Pharmacokinetics and safety of letermovir coadministered with cyclosporine A or tacrolimus in healthy subjects. Clin Pharmacol Drug Dev. 2018;7(1):9-21.
-
(2018)
Clin Pharmacol Drug Dev
, vol.7
, Issue.1
, pp. 9-21
-
-
Kropeit, D.1
von Richter, O.2
Stobernack, H.P.3
Rubsamen-Schaeff, H.4
Zimmermann, H.5
-
17
-
-
77955994141
-
Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin
-
Amundsen R, Christensen H, Zabihyan B, Asberg A. Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin. Drug Metab Dispos. 2010;38(9):1499-1504.
-
(2010)
Drug Metab Dispos
, vol.38
, Issue.9
, pp. 1499-1504
-
-
Amundsen, R.1
Christensen, H.2
Zabihyan, B.3
Asberg, A.4
|